首页> 外文期刊>Science >Structural basis of G_s and G_i recognition by the human glucagon receptor
【24h】

Structural basis of G_s and G_i recognition by the human glucagon receptor

机译:人胰高血糖素受体的G_S和G_I识别的结构基础

获取原文
获取原文并翻译 | 示例
           

摘要

Class B G protein-coupled receptors, an important class of therapeutic targets, signal mainly through the G(s) class of heterotrimeric G proteins, although they do display some promiscuity in G protein binding. Using cryo-electron microscopy, we determined the structures of the human glucagon receptor (GCGR) bound to glucagon and distinct classes of heterotrimeric G proteins, G(s) or G(i1). These two structures adopt a similar open binding cavity to accommodate G(s) and G(i1). The G(s) binding selectivity of GCGR is explained by a larger interaction interface, but there are specific interactions that affect G(i) more than G(s) binding. Conformational differences in the receptor intracellular loops were found to be key selectivity determinants. These distinctions in transducer engagement were supported by mutagenesis and functional studies.
机译:B类G蛋白偶联受体,一类重要的治疗靶标,主要通过G(S)类型异映型G蛋白,尽管它们确实显示了G蛋白结合中的一些滥交。使用低温电子显微镜,确定人胰血糖素受体(GCGR)的结构与胰胰高血糖素和不同类别的异映射蛋白,G(S)或G(I1)结合。这两个结构采用类似的开口粘合腔以容纳G(S)和G(I1)。通过更大的相互作用界面来解释GCGR的G(S)结合选择性,但是有特定的相互作用,其影响G(i)比g(s)结合多于g。发现受体细胞内环的构象差异是关键选择性决定因素。通过诱变和功能研究支持换能器接合中的这些区别。

著录项

  • 来源
    《Science》 |2020年第6484期|1346-1352|共7页
  • 作者单位

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;

    Univ Chinese Acad Sci Beijing 100049 Peoples R China|Chinese Acad Sci Natl Lab Biomacromol Natl Ctr Prot Sci Beijing CAS Ctr Excellence Biomacromol Inst Biophys Beijing 100101 Peoples R China;

    Fudan Univ Sch Pharm Shanghai 201203 Peoples R China;

    Monash Univ Drug Discovery Biol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia|Monash Univ Dept Pharmacol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Fudan Univ Sch Pharm Shanghai 201203 Peoples R China;

    Univ Chinese Acad Sci Beijing 100049 Peoples R China|Chinese Acad Sci Natl Lab Biomacromol Natl Ctr Prot Sci Beijing CAS Ctr Excellence Biomacromol Inst Biophys Beijing 100101 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China;

    Novo Nordisk AS DK-2760 Malov Denmark;

    Novo Nordisk AS DK-2760 Malov Denmark;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med Shanghai 201203 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China|Fudan Univ Sch Pharm Shanghai 201203 Peoples R China|Chinese Acad Sci Natl Ctr Drug Screening Shanghai Inst Mat Med Shanghai 201203 Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai 201210 Peoples R China;

    Fudan Univ Sch Pharm Shanghai 201203 Peoples R China|Monash Univ Drug Discovery Biol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia|Monash Univ Dept Pharmacol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia;

    Fudan Univ Sch Pharm Shanghai 201203 Peoples R China|Monash Univ Drug Discovery Biol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia|Monash Univ Dept Pharmacol Monash Inst Pharmaceut Sci Parkville Vic 3052 Australia;

    Univ Chinese Acad Sci Beijing 100049 Peoples R China|Chinese Acad Sci Natl Lab Biomacromol Natl Ctr Prot Sci Beijing CAS Ctr Excellence Biomacromol Inst Biophys Beijing 100101 Peoples R China|Chinese Acad Sci Ctr Biol Imaging Inst Biophys Beijing 100101 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med State Key Lab Drug Res Shanghai 201203 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China|Chinese Acad Sci CAS Ctr Excellence Biomacromol Beijing 100101 Peoples R China;

    Chinese Acad Sci Shanghai Inst Mat Med CAS Key Lab Receptor Res Shanghai 201203 Peoples R China|Univ Chinese Acad Sci Beijing 100049 Peoples R China|ShanghaiTech Univ Sch Life Sci & Technol Shanghai 201210 Peoples R China|Chinese Acad Sci CAS Ctr Excellence Biomacromol Beijing 100101 Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号